Working on ''Eleventh Hour''

Creator of UK science-fiction series explains how science TV dramas can produce backstage dramas of their own

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share
Here in the UK there's a template for science-based TV drama. It goes like this: a broadcaster fixes upon a hot issue of the day, assigns a writer to fashion a 'human drama' around it, and locates some qualified scientist to advise the production. The press office issues a release asserting that "this is science fact, not science fiction."Then about two weeks before the show goes out, the science advisor -- who maybe gave notes on the first-draft script and then saw nothing more of it until the cast-and-crew screening -- loudly and publicly withdraws from the entire enterprise. When it airs, any dramatic merit is far overshadowed by arguments over whether its "science fact" can stand up to inspection. The producers, who usually have no idea one way or the other, fall back on the argument that they were simply trying to "raise the issues for discussion."And at the end of the day, nobody's happy. Especially the audience, who can deal with both science fiction and real-world science (for what else are the medical situations in House or ER?), but will always be cool toward drama that has no clear idea of what it's supposed to be.Last year, I had a crack at breaking the template as the creator of a major series of feature-length TV movies for the ITV network entitled Eleventh Hour, starring Patrick Stewart, of Star Trek and X-Men fame. Stewart played Professor Hood, a senior advisor to the UK government, whose job it is to deal with any crisis of contemporary science before it has a chance to escalate. He was conceived as an emeritus physics professor with few domestic ties, living out of a suitcase and so unafraid of clashing with others that he needs a full-time bodyguard to protect him from reprisals. In short, the scientist as an old-style hero in an up-to-date setting. Hood grew out of a promise I once made to the biochemist Paul Nurse that I would someday try to put real science into a popular TV drama. He'd been unhappy with aspects of my teleplay of Chimera, a science fictional miniseries about a rampaging human-ape hybrid, which followed the traditional practice of casting science itself as the real villain. (For which I don't apologize, by the way; science always makes a damned good villain, and the theme of 'creator undone by his creation' is an enduring one.)My plan for breaking the "bad science" template was a simple one: Pick hot topics, research them properly, and only then build narrative from the stories and surprises that come out of the research. This involved the same commitment to accurate detail that's taken for granted in other fields of drama -- the cases in Law & Order may be fictionalized, for example, but they don't make up their own laws as well. Selling the idea was challenging, but I wasn't prepared for the level of active hostility I was to meet along the way from an arts-educated mindset that felt it could match any scientific opinion with an equally valid opinion of its own. If I ever needed a reminder of what we needed to avoid, I had only to think of Hear the Silence, a recent drama that had wholly embraced the notion of a causal link between the MMR vaccine and autism -- unproven then, discredited since -- to the horror of health professionals. But it wasn't simply a matter of scientific probity for probity's sake: Hear the Silence is remembered only for the controversy surrounding it, not as good drama.I was quickly outnumbered and outvoted. My readiness to take on board our science consultant's input was "letting the tail wag the dog". A note on a virus outbreak story read: "At the very last moment Hood should invent a new antidote to smallpox." Another suggestion cited depleted uranium (DU) as the proven cause of Gulf War Syndrome. When our science advisor supplied data on the actual toxicity and effects of DU, one response was, "I disagree." My own contribution was meanwhile cut from four scripts to two.A week before shooting began, I got a phone call to say that my two completed scripts were being taken out of my hands to be given a last-minute "polish" by the producers. There was nothing I could do other than watch the battle move on without me. So how did it turn out? Did Eleventh Hour fulfill the promise I'd made? There were some victories. Most reviewers responded to the foregrounding of science and the positive, pro-science role played by its protagonist. But on the downside, Reuters criticized the show's over-reliance on unsupported scientific rhetoric. And Lord Robert May, a former chief scientific adviser to the UK Government (and Hood's real-life -- if perhaps less swashbuckling -- counterpart), was caustic in criticizing the way that the science in the shows was "melodramatically misrepresented," and frequently inaccurate.But for me, the most telling criticism came when I was taken to task by a science teacher, angry because his pupils absorb assumptions from TV that he can never fully dispel. Science is all theories, they seem to suppose, and one theory's as good as any other. And that's why it matters to get it right -- not for the scientists or the specialists, but for the ordinary viewer who can't be expected to know when it's wrong. So, no. I don't believe I've delivered on my promise. Yet. Stephen Gallagher sgallagher@the-scientist.comLinks within this articleA.Grimwade, "Glued to another tube," The Scientist, April 21, 2003. http://www.the-scientist.com/article/display/13732/B. Maher, "Get me the NIH," The Scientist, September 24, 2004. http://www.the-scientist.com/article/display/14945/H. Black, "Science goes to the movies," The Scientist, June 17, 2004. http://www.the-scientist.com/article/display/22233/L. Nordling, "Boffins on the box," Guardian, January 17, 2006. http://education.guardian.co.uk/higher/research/notes/story/0,16508,1687600,00.htmlK. Hopkin, "Coming full cycle," The Scientist, May 1, 2006. http://www.the-scientist.com/article/display/23370/I.Ganguli, "A lab goes to Hollywood," The Scientist, March 1, 2006. http://www.the-scientist.com/article/display/23150/
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • Stephen Gallagher

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development